Antimicrobial Resistance of 914 Beta-Hemolytic Streptococci Isolated from Pharyngeal Swabs in Spain: Results of a 1-Year (1996–1997) Multicenter Surveillance Study

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 43; no. 1; pp. 178 - 180
Main Authors BAQUERO, F, GARCIA-RODRIGUEZ, J. A, GARCIA DE LOMAS, J, AGUILAR, L
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.01.1999
SeriesNote
Subjects
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
Pharynx
Streptococcal Infections
Streptococcus
Streptococcus equisimilis
Streptococcus pyogenes
Susceptibility
Europe
Spain
Human
Streptococcaceae
Antibiotic
Microorganism resistance
Streptococcus
Respiratory disease
Minimum inhibitory concentration
Bacteria
Micrococcales
Pharynx disease
Antibacterial agent
In vitro
Online AccessGet full text

Cover

More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Composed of M. Gobernado and N. Diosdado, La Fe Hospital, Valencia; E. Bouza and E. Cercenado, Gregorio Marañón Hospital, Madrid; A. Gutierrez and A. García, La Paz Hospital, Madrid; R. Cisterna and A. Morla, Basurto Hospital, Bilbao; E. Perea and L. Martínez, Virgen Macarena Hospital, Seville; M. de la Rosa and A. Martínez-Brocal, Virgen de las Nieves Hospital, Granada; M. Casal and A. Ibarra, Reina Sofía Hospital, Córdoba; I. Trujillano, Clinico Universitario Hospital, Salamanca; R. Gómez-Lus and M. C. Rubio, Clinico Universitario Hospital, Zaragoza; A. C. Gómez-García and F. J. Blanco-Palenciano, Infanta Cristina Hospital, Badajoz; C. García-Riestra and I. Rodríguez, Xeral de Galicia Hospital, Santiago de Compostela; C. Gimeno and D. Navarro, Instituto Valenciano de Microbiología, Valencia; and A. Torrellas, J. J. Granizo, R. Moreno, and R. Dal-Ré, SmithKline Beecham Pharmaceuticals, Madrid, Spain.
Corresponding author. Mailing address: Departamento Médico, SmithKline Beecham Pharmaceuticals, Valle de la Fuenfría, 3, 28034 Madrid, Spain. Phone: 34-91-3345275. Fax: 34-91-3345141. E-mail: lorenzo.aguilar-alfaro@sb.com.
ISSN:0066-4804
1098-6596
DOI:10.1128/aac.43.1.178